Page 408 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHAPtER 26 Host Defenses to Intracellular Bacteria 389

9. Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of 34. Masaki T, Qu J, Cholewa-Waclaw J, et al. Reprogramming adult Schwann
human brucellosis. Lancet Infect Dis 2006;6:91–9. cells to stem cell-like cells by leprosy bacilli promotes dissemination of
10. Pathela P, Blank S, Schillinger JA. Lymphogranuloma venereum: old infection. Cell 2013;152:51–67.
pathogen, new story. Curr Infect Dis Rep 2007;9:143–50. 35. Stavru F, Archambaud C, Cossart P. Cell biology and immunology of
11. Limmathurotsakul D, Golding N, Dance DA, et al. Predicted global Listeria monocytogenes infections: novel insights. Immunol Rev
distribution of and burden of melioidosis. Nat Microbiol 2016;1: 2011;240:160–84.
15008. 36. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev
12. Sjostedt A. Intracellular survival mechanisms of Francisella tularensis, a Immunol 2009;27:393–422.
stealth pathogen. Microbes Infect 2006;8:561–7. 37. van der Wel N, Hava D, Houben D, et al. M. tuberculosis and M. leprae
13. Dooling KL, Toews KA, Hicks LA, et al. Active Bacterial Core Surveillance translocate from the phagolysosome to the cytosol in myeloid cells. Cell
for Legionellosis - United States, 2011-2013. MMWR Morb Mortal Wkly 2007;129:1287–98.
Rep 2015;64:1190–3. 38. Iwakura Y, Ishigame H, Saijo S, et al. Functional specialization of
14. Land JA, Van Bergen JE, Morre SA, et al. Epidemiology of Chlamydia interleukin-17 family members. Immunity 2011;34:149–62.
trachomatis infection in women and the cost-effectiveness of screening. 39. Lin Y, Ritchea S, Logar A, et al. Interleukin-17 is required for T helper 1
Hum Reprod Update 2010;16:189–204. cell immunity and host resistance to the intracellular pathogen Francisella
15. Wright HR, Turner A, Taylor HR. Trachoma. Lancet 2008;371: tularensis. Immunity 2009;31:799–810.
1945–54. 40. O’Shea JJ, Paul WE. Mechanisms underlying lineage commitment and
16. Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the plasticity of helper CD4+ T cells. Science 2010;327:1098–102.
world: emerging diseases challenging old concepts. Clin Microbiol Rev 41. Cox MA, Harrington LE, Zajac AJ. Cytokines and the inception of CD8 T
2005;18:719–56. cell responses. Trends Immunol 2011;32:180–6.
17. Winslow GM, Bitsaktsis C. Immunity to the ehrlichiae: new tools and 42. Walch M, Dotiwala F, Mulik S, et al. Cytotoxic cells kill intracellular
recent developments. Curr Opin Infect Dis 2005;18:217–21. bacteria through granulysin-mediated delivery of granzymes. Cell
18. Biswas S, Rolain JM. Bartonella infection: treatment and drug resistance. 2014;157:1309–23.
Future Microbiol 2010;5:1719–31. 43. Bonneville M, O’Brien RL, Born WK. Gammadelta T cell effector
19. Dorhoi A, Reece ST, Kaufmann SH. For better or for worse: the immune functions: a blend of innate programming and acquired plasticity. Nat
response against Mycobacterium tuberculosis balances pathology and Rev Immunol 2010;10:467–78.
protection. Immunol Rev 2011;240:235–51. 44. Ussher JE, Klenerman P, Willberg CB. Mucosal-associated invariant
20. Kaufmann SHE, Dorhoi A. Molecular determinants in phagocyte-bacteria T-cells: new players in anti-bacterial immunity. Front Immunol
interactions. Immunity 2016;44:476–91. 2014;5:450.
21. Yin Q, Fu TM, Li J, et al. Structural biology of innate immunity. Annu 45. Napier RJ, Adams EJ, Gold MC, et al. The role of mucosal associated
Rev Immunol 2015;33:393–416. invariant T cells in antimicrobial immunity. Front Immunol 2015;6:344.
22. Taylor PR, Martinez-Pomares L, Stacey M, et al. Macrophage receptors 46. Corbett AJ, Eckle SB, Birkinshaw RW, et al. T-cell activation by transitory
and immune recognition. Annu Rev Immunol 2005;23:901–44. neo-antigens derived from distinct microbial pathways. Nature 2014;509:
23. Netea MG. Training innate immunity: the changing concept of 361–5.
immunological memory in innate host defence. Eur J Clin Invest 47. Brigl M, Brenner MB. CD1: antigen presentation and T cell function.
2013;43:881–4. Annu Rev Immunol 2004;22:817–90.
24. Le Y, Zhou Y, Iribarren P, et al. Chemokines and chemokine receptors: 48. Darmoise A, Teneberg S, Bouzonville L, et al. Lysosomal
their manifold roles in homeostasis and disease. Cell Mol Immunol alpha-galactosidase controls the generation of self lipid antigens for
2004;1:95–104. natural killer T cells. Immunity 2010;33:216–28.
25. Cambier CJ, Takaki KK, Larson RP, et al. Mycobacteria manipulate 49. Lanzavecchia A, Sallusto F. Understanding the generation and function of
macrophage recruitment through coordinated use of membrane lipids. memory T cell subsets. Curr Opin Immunol 2005;17:326–32.
Nature 2014;505:218–22. 50. Mueller SN, Gebhardt T, Carbone FR, et al. Memory T cell subsets,
26. Werner E. GTPases and reactive oxygen species: switches for killing and migration patterns, and tissue residence. Annu Rev Immunol 2013;31:
signaling. J Cell Sci 2004;117:143–53. 137–61.
27. Bogdan C. Nitric oxide and the immune response. Nat Immunol 51. Scott P. Immunologic memory in cutaneous leishmaniasis. Cell Microbiol
2001;2:907–16. 2005;7:1707–13.
28. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons 52. Joller N, Weber SS, Oxenius A. Antibody-Fc receptor interactions in
in the arsenal. Nat Rev Immunol 2003;3:361–70. protection against intracellular pathogens. Eur J Immunol 2011;41:
29. Rudel T, Kepp O, Kozjak-Pavlovic V. Interactions between bacterial 889–97.
pathogens and mitochondrial cell death pathways. Nat Rev Microbiol 53. Neves P, Lampropoulou V, Calderon-Gomez E, et al. Signaling via the
2010;8:693–705. MyD88 adaptor protein in B cells suppresses protective immunity during
30. Brumell JH, Scidmore MA. Manipulation of rab GTPase function by Salmonella typhimurium infection. Immunity 2010;33:777–90.
intracellular bacterial pathogens. Microbiol Mol Biol Rev 2007;71: 54. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat
636–52. Immunol 2005;6:353–60.
31. Salcedo SP, Holden DW. Bacterial interactions with the eukaryotic 55. Kaufmann SH, Lange C, Rao M, et al. Progress in tuberculosis vaccine
secretory pathway. Curr Opin Microbiol 2005;8:92–8. development and host-directed therapies-a state of the art review. Lancet
32. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators Respir Med 2014;2:301–20.
of the immune system. Nat Rev Immunol 2009;9:162–74.
33. Knaul JK, Jorg S, Oberbeck-Mueller D, et al. Lung-residing
myeloid-derived suppressors display dual functionality in murine
pulmonary tuberculosis. Am J Respir Crit Care Med 2014;190:1053–66.